Fusion Pharmaceuticals completes venture financing

On Feb. 23, radiotherapeutics company Fusion Pharmaceuticals Inc. (Hamilton, Ontario) raised $25 million in a series A round led by existing investor Johnson & Johnson Innovation-JJDC Inc. New investo...